Fundsmith LLP’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.8M Buy
2,709,086
+557,812
+26% +$12.1M 0.26% 32
2025
Q1
$52.2M Buy
+2,151,274
New +$52.2M 0.24% 35